Childhood diabetes rates surge globally

UCB’s treat­ment can­di­dates for plaque pso­ri­a­sis and gen­er­al­ized myas­the­nia gravis have both bagged ap­provals in the US, ex­pand­ing cur­rent mar­ket op­por­tu­ni­ties and open­ing up new

Nearly 350,000 Medtronic implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators are under Class I recall for potentially producing low-energy shocks, according to the FDA. Another